CASTRES, France, November 21, 2011 - The Therapeutic Goods Administration (TGA), Australia's regulatory body for therapeutic products, granted Pierre Fabre Mdicament's milnacipran market authorisation for the treatment of fibromyalgia ("for the management of fibromyalgia").
CASTRES, France, October 13, 2011 - Pierre Fabre Laboratorieshave beenopposed to the sale of dermo-cosmetic products on the Internet for many years.
CASTRES, France, September 1, 2010 - During its first meeting, the Board of Directors of Pierre Fabre SA chaired by Mr.
CASTRES, France, July 2, 2010 - Olivier Bohuon will be replacing Jean-Pierre Garnier as Chief Executive Officer at Pierre Fabre Group starting September 1, 2010.
CASTRES, France, June 28, 2010 - Mr Jean-Pierre Garnier will step down on September 1st 2010, two years after having been appointed CEO of the Pierre Fabre Group.
- Internet Sales of Dermocosmetics: the Paris Court of Appeal Refers the Case to the Court of Justice of the European Communities
- Positive CHMP Opinion for JAVLOR(R) in Metastatic Treatment of Bladder Cancer After Failure of a Prior Platinum-Containing Regimen
- Pierre Fabre Dermatologie Starts Clinical Trials on a Beta-Blocker to Treat Severe Infantile Haemangioma